abacavir

Generic: abacavir sulfate

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abacavir
Generic Name abacavir sulfate
Labeler rising pharma holdings, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

abacavir sulfate 20 mg/mL

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 64980-405
Product ID 64980-405_5f703bb1-ffca-47fe-a019-9e5b31ab8294
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077950
Listing Expiration 2026-12-31
Marketing Start 2018-03-14

Pharmacologic Class

Classes
cytochrome p450 1a1 inhibitors [moa] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 64980405
Hyphenated Format 64980-405

Supplemental Identifiers

RxCUI
242680
UNII
J220T4J9Q2

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abacavir (source: ndc)
Generic Name abacavir sulfate (source: ndc)
Application Number ANDA077950 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (64980-405-24) / 240 mL in 1 BOTTLE
source: ndc

Packages (1)

Ingredients (1)

abacavir sulfate (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5f703bb1-ffca-47fe-a019-9e5b31ab8294", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242680"], "spl_set_id": ["ec9e2c36-b9b7-4ac2-a366-f3ad51237f28"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (64980-405-24)  / 240 mL in 1 BOTTLE", "package_ndc": "64980-405-24", "marketing_start_date": "20180314"}], "brand_name": "Abacavir", "product_id": "64980-405_5f703bb1-ffca-47fe-a019-9e5b31ab8294", "dosage_form": "SOLUTION", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "64980-405", "generic_name": "Abacavir Sulfate", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "20 mg/mL"}], "application_number": "ANDA077950", "marketing_category": "ANDA", "marketing_start_date": "20180314", "listing_expiration_date": "20261231"}